Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events international congress parkinson’s disease movement disorders mds virtual
… the healthcare industry and working in highly competitive international markets. He has a proven history of driving … with Broward Health where he served as the health system’s International Business Development Coordinator. During this …
… profession, community, and North Carolina State University’s Edward P. Fitts Department of Industrial and Systems … award, and I'm completely honored.” To see Dr. Earnshaw’s acceptance speech, visit NCSU’s Distinguished Alumni webpage here . Related Services …
… case series analyses of specific severe adverse events as well as for monitoring the effectiveness of …
… has over 30 years of experience in the research-driven international pharmaceutical environment, developing and … is an active leader and past president of the International Society of Pharmacoepidemiology (ISPE) and past … and chair conferences and symposia. Dr. Perez-Gutthann's roles as an advisor and in international working groups …
… of quality assurance, clinical intervention studies, and disease management programs. Ms. Bui has experience managing …
… and business partner networks. She has coordinated international product launches and conferences and provided …
… settings, particularly in orthopedic and infectious disease conditions. These measures have focused on … published in the Journal of Shoulder and Elbow Surgery International, Telemedicine and E-Health, Medical Care, and …
… to joining RTI-HS, Ms. Kosa was a research analyst at RTI International in the Food, Nutrition, and Obesity Research … (USDA), US Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), and the Crohn's & Colitis Foundation. …
… of respiratory and cardiovascular diseases. She has led international multidatabase post-authorization studies, …
… advantage for the selected drug in its indication(s). Sources can include head-to-head randomized controlled … and preferences, treatment burden, and burden of disease. Another important addition to the ICR for IPAY 2027 … potential therapeutic alternatives. Evidence may include disease burden or cost-of-illness analyses, and …